[{"address1": "1375 West Fulton Street", "address2": "Suite 1300", "city": "Chicago", "state": "IL", "zip": "60607", "country": "United States", "phone": "844 445 5704", "website": "https://www.xerispharma.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Xeris Biopharma Holdings, Inc., a commercial-stage biopharmaceutical company, engages in developing and commercializing therapies for chronic endocrine and neurological diseases in Illinois. The company offers Gvoke, a ready-to-use liquid-stable glucagon for the treatment of severe hypoglycemia in pediatric and adult patients; Keveyis, a therapy for the treatment of hyperkalemic, hypokalemic, and related variants of primary periodic paralysis; and Recorlev, a cortisol synthesis inhibitor for the treatment of endogenous hypercortisolemia in adult patients with Cushing's syndrome. It is also developing XP-8121, a once-weekly subcutaneous injection of levothyroxine that is in phase 3 clinical trial for the treatment of hypothyroidism. The company was incorporated in 2005 and is headquartered in Chicago, Illinois.", "fullTimeEmployees": 394, "companyOfficers": [{"maxAge": 1, "name": "Mr. John P. Shannon", "age": 62, "title": "CEO & Director", "yearBorn": 1962, "fiscalYear": 2024, "totalPay": 1065572, "exercisedValue": 0, "unexercisedValue": 341267}, {"maxAge": 1, "name": "Mr. Kevin  McCulloch", "age": 61, "title": "President & COO", "yearBorn": 1963, "fiscalYear": 2024, "totalPay": 777048, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Steven M. Pieper", "age": 47, "title": "Chief Financial Officer", "yearBorn": 1977, "fiscalYear": 2024, "totalPay": 747017, "exercisedValue": 30004, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Beth P. Hecht J.D.", "age": 60, "title": "Chief Legal Officer & Corporate Secretary", "yearBorn": 1964, "fiscalYear": 2024, "totalPay": 767825, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Paul R. Edick J.D.", "age": 68, "title": "Senior Advisor", "yearBorn": 1956, "fiscalYear": 2024, "totalPay": 2597639, "exercisedValue": 0, "unexercisedValue": 1357712}, {"maxAge": 1, "name": "Ms. Allison  Wey", "title": "Senior Vice President of Investor Relations & Corporate Communications", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Brian  Conner", "title": "SVP of Quality and Chief Compliance & Risk Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Kendal  Korte", "title": "Senior Vice President of Human Resources", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Anh  Nguyen M.B.A., M.D.", "age": 49, "title": "Chief Medical Officer", "yearBorn": 1975, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 5, "boardRisk": 7, "compensationRisk": 8, "shareHolderRightsRisk": 8, "overallRisk": 7, "governanceEpochDate": 1761955200, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 7.26, "open": 7.1122, "dayLow": 7.01, "dayHigh": 7.32, "regularMarketPreviousClose": 7.26, "regularMarketOpen": 7.1122, "regularMarketDayLow": 7.01, "regularMarketDayHigh": 7.32, "payoutRatio": 0.0, "beta": 0.922, "forwardPE": -32.636364, "volume": 2921032, "regularMarketVolume": 2921032, "averageVolume": 2411932, "averageVolume10days": 3981250, "averageDailyVolume10Day": 3981250, "bid": 5.24, "ask": 9.02, "bidSize": 2, "askSize": 2, "marketCap": 1204610304, "fiftyTwoWeekLow": 2.82, "fiftyTwoWeekHigh": 10.08, "allTimeHigh": 27.98, "allTimeLow": 0.97, "priceToSalesTrailing12Months": 4.526279, "fiftyDayAverage": 8.348, "twoHundredDayAverage": 5.85605, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 1357392384, "profitMargins": -0.058769997, "floatShares": 158689990, "sharesOutstanding": 165924289, "sharesShort": 17626897, "sharesShortPriorMonth": 17441089, "sharesShortPreviousMonthDate": 1759190400, "dateShortInterest": 1761868800, "sharesPercentSharesOut": 0.1062, "heldPercentInsiders": 0.039189998, "heldPercentInstitutions": 0.59323, "shortRatio": 8.01, "shortPercentOfFloat": 0.1104, "impliedSharesOutstanding": 167773028, "bookValue": -0.005, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1759190400, "netIncomeToCommon": -15640000, "trailingEps": -0.1, "forwardEps": -0.22, "enterpriseToRevenue": 5.1, "enterpriseToEbitda": 48.416, "52WeekChange": 1.475862, "SandP52WeekChange": 0.14261019, "quoteType": "EQUITY", "currentPrice": 7.18, "targetHighPrice": 18.0, "targetLowPrice": 8.0, "targetMeanPrice": 11.5, "targetMedianPrice": 10.5, "recommendationMean": 1.4, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 6, "totalCash": 91598000, "totalCashPerShare": 0.552, "ebitda": 28036000, "totalDebt": 257654000, "quickRatio": 1.251, "currentRatio": 1.928, "totalRevenue": 266136992, "revenuePerShare": 1.704, "returnOnAssets": 0.02875, "grossProfits": 225036992, "freeCashflow": 28553500, "operatingCashflow": 10558000, "revenueGrowth": 0.371, "grossMargins": 0.84556997, "ebitdaMargins": 0.105340004, "operatingMargins": 0.09049, "financialCurrency": "USD", "symbol": "XERS", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "regularMarketChangePercent": -1.10193, "regularMarketPrice": 7.18, "shortName": "Xeris Biopharma Holdings, Inc.", "longName": "Xeris Biopharma Holdings, Inc.", "corporateActions": [], "postMarketTime": 1763154908, "regularMarketTime": 1763154000, "exchange": "NMS", "messageBoardId": "finmb_105901792", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "fiftyDayAverageChange": -1.1679997, "fiftyDayAverageChangePercent": -0.13991372, "twoHundredDayAverageChange": 1.3239498, "twoHundredDayAverageChangePercent": 0.2260824, "priceToBook": -1436.0, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "prevName": "Xeris Pharmaceuticals, Inc.", "nameChangeDate": "2025-11-14", "averageAnalystRating": "1.4 - Strong Buy", "cryptoTradeable": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1529587800000, "postMarketChangePercent": -0.13927232, "postMarketPrice": 7.17, "postMarketChange": -0.009999752, "regularMarketChange": -0.0800004, "regularMarketDayRange": "7.01 - 7.32", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 2411932, "fiftyTwoWeekLowChange": 4.3599997, "fiftyTwoWeekLowChangePercent": 1.5460992, "fiftyTwoWeekRange": "2.82 - 10.08", "fiftyTwoWeekHighChange": -2.9, "fiftyTwoWeekHighChangePercent": -0.28769842, "fiftyTwoWeekChangePercent": 147.5862, "earningsTimestamp": 1762435800, "earningsTimestampStart": 1762435800, "earningsTimestampEnd": 1762435800, "earningsCallTimestampStart": 1762435800, "earningsCallTimestampEnd": 1762435800, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": -0.1, "epsForward": -0.22, "epsCurrentYear": -0.04, "priceEpsCurrentYear": -179.5, "marketState": "CLOSED", "displayName": "Xeris Biopharma", "trailingPegRatio": null, "__fetch_time": "2025-11-15"}]